Histopathological and biochemical profiling of Carfilzomib-loaded Fe–Co MOFs
Abstract In recent years, new medications like proteasome inhibitors (PIs) have significantly improved cancer patients’ response rate and overall survival. Carfilzomib (CFZ), a second-generation proteasome inhibitor, has shown promising results in clinical trials for treating multiple myeloma patien...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-08-01
|
| Series: | Discover Nano |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s11671-025-04334-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|